Young children may learn deception for their benefit within 10 days, a new study shows. Moreover, the children’s capacities for hiding truthful information and for representing mental life determine the rate at which they learn deception.
It appears that evidence-based psychotherapy and antidepressant medication are both effective in the management of nonpsychotic major depression, according to the PReDICT* study, suggesting that guidelines recommending either treatment can be extended to treatment-naïve patients.
Imaging-based depression subtypes defined using resting-state functional connectivity differentially identifies the chance of remission or treatment failure with first-line treatment options in individuals with major depressive disorder, a recent study suggests.
There are about twice as many patients who improved with antipsychotics as with placebo, but a good response is seen only in a minority, according to a study. Additionally, industry sponsorship and increasing placebo response, not decreasing drug response, reduce effect sizes.
New drug applications approved by US FDA as of 15 – 31 May 2015 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.